Liposomes were tested for visual assessment, PS (190270 nm), ZP and drug encapsulation (10%)
Other drugs similar to the GLP1 molecule, such as Saxenda (liraglutide), have shown comparable effects on weight loss, with results ranging from 5% to 10% of the initial weight
Semaglutide has transformed weight loss treatment since its approval as Wegovy in 2021, helping patients reduce body weight by 1522% in clinical trials
By doing this, it helps with weight reduction and also aids in managing blood sugar levels
It is fair-balance context, not a recommendation to buy
Current Pipeline The current pipeline for GLP-1 RAs is robust with 1,465 clinical trials in various stages